EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Proteome analysis develops novel plasma proteins classifier in predicting the mortality of COVID ‐19

Yifei Zeng, Yufan Li, Wanying Zhang, Huidan Lu, Siyi Lin, Wenting Zhang, Lexin Xia, Huiqun Hu, Yuanlin Song, Feng Xu iD

Cell Proliferation · 2024

DOI: 10.1111/cpr.13617 ↗

At a glance

Journal article in Cell Proliferation, 2024. Written by Yifei Zeng and 9 co-authors. Institution: Department of Infectious Diseases, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. Major MEDLINE topics: COVID-19, Blood Proteins, Proteome, Proteomics. Cited 3 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Binjiang Institute of Zhejiang University, Qianjiang Distinguished Scholar Program from Hangzhou City.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

COVID‐19 has been a global concern for 3 years, however, consecutive plasma protein changes in the disease course are currently unclear. Setting the mortality within 28 days of admission as the main clinical outcome, plasma samples were collected from patients in discovery and independent validation groups at different time points during the disease course. The whole patients were divided into death and survival groups according to their clinical outcomes. Proteomics and pathway/network analyses were used to find the differentially expressed proteins and pathways. Then, we used machine learning to develop a protein classifier which can predict the clinical outcomes of the patients with COVID‐19 and help identify the high‐risk patients. Finally, a classifier including C‐reactive protein, extracellular matrix protein 1, insulin‐like growth factor‐binding protein complex acid labile subunit, E3 ubiquitin‐protein ligase HECW1 and phosphatidylcholine‐sterol acyltransferase was determined. The prediction value of the model was verified with an independent patient cohort. This novel model can realize early prediction of 28‐day mortality of patients with COVID‐19, with the area under curve 0.88 in discovery group and 0.80 in validation group, superior to 4C mortality and E‐CURB65 scores. In total, this work revealed a potential protein classifier which can assist in predicting the outcomes of COVID‐19 patients and providing new diagnostic directions.

Subjects

MeSH terms (MEDLINE)

COVID-19Blood ProteinsProteomeProteomicsHumansMaleFemaleMiddle AgedAgedSARS-CoV-2Machine LearningPrognosisBiomarkers

Substances

Blood ProteinsProteomeBiomarkers

Authors and institutions

  • Department of Infectious Diseases, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Shanghai Key Laboratory of Lung Inflammation and Injury, Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Key Laboratory of Multiple Organ Failure (Zhejiang University), Ministry of Education, Hangzhou, China.
  • Research Center for Life Science and Human Health, Binjiang Institute of Zhejiang University, Hangzhou, China.

ORCID profiles: Feng Xu

Funding

  • National Natural Science Foundation of China
  • Binjiang Institute of Zhejiang University
  • Qianjiang Distinguished Scholar Program from Hangzhou City

Cite

APA

Zeng, Y., Li, Y., Zhang, W., Lu, H., Lin, S., Zhang, W., Xia, L., Hu, H., Song, Y., & Xu, F. (2024). Proteome analysis develops novel plasma proteins classifier in predicting the mortality of COVID ‐19. Cell Proliferation. https://doi.org/10.1111/cpr.13617

Vancouver

Zeng Y, Li Y, Zhang W, Lu H, Lin S, Zhang W, et al. Proteome analysis develops novel plasma proteins classifier in predicting the mortality of COVID ‐19. Cell Proliferation. 2024. doi:10.1111/cpr.13617

BibTeX
@article{Zeng2024,
  author = {Zeng, Yifei and Li, Yufan and Zhang, Wanying and Lu, Huidan and Lin, Siyi and Zhang, Wenting and Xia, Lexin and Hu, Huiqun and Song, Yuanlin and Xu, Feng},
  title = {Proteome analysis develops novel plasma proteins classifier in predicting the mortality of COVID ‐19},
  journal = {Cell Proliferation},
  year = {2024},
  doi = {10.1111/cpr.13617}
}
Start for free →